(CSL) |
0 (0%) 10-10 13:32 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 398.95 |
Resistance 1: | 366.86 |
Pivot price: | 329.28 |
Support 1: | 314.95 |
Support 2: | 262.04 |
52w High: | |
52w Low: |
EPS | 17.860 |
Book Value | 49.900 |
PEG Ratio | 0.00 |
Gross Profit | 43.275 |
Profit Margin (%) | 16.12 |
Operating Margin (%) | 23.20 |
Return on Assets (ttm) | 10.6 |
Return on Equity (ttm) | 31.4 |
Fri, 10 Oct 2025
Saudi Arabia Adult Vaccine Market Forecast Report 2025-2033 Featuring Company Analysis and Vaccine Sales of GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, CSL Limited - ResearchAndMarkets.com - Business Wire
Thu, 09 Oct 2025
CSL (ASX:CSL) Insights: Why Investors Are Watching Closely - Kalkine Media
Wed, 08 Oct 2025
Vifor to cut 55 jobs as parent company CSL pushes ahead with downsizing, savings drive - Fierce Pharma
Wed, 08 Oct 2025
Fanatec is refreshing its classics: From CSL McLaren to CSL GT3 - BoxThisLap
Tue, 07 Oct 2025
CSL Consulting Expands Presence in the Southeastern U.S.; Announces Strategic Partnership with Brownstone Construction Group - Charleston Business
Mon, 06 Oct 2025
Fanatec Launches New Xbox-Licensed GT3-Style Wheel for the CSL Series - TechPowerUp
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |